Gilead’s remdesivir tested with other drugs to fight COVID-19

Wall Street Journal

13 May 2020 - Researchers are looking to find a more potent coronavirus-fighting cocktail.

The promise and limitations of remdesivir, the first drug to prove capable of helping fight COVID-19, have kicked off efforts to see if it can work better in combination with other treatments and to create new, easier methods of administering it.

Researchers are exploring whether the drug, made by Gilead Sciences, can be combined with other antiviral treatments to make a more potent coronavirus-fighting cocktail.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Drug development , COVID-19